Slavc I - Search Results

1

Bridging the gap: A quality improvement project to implement psychosocial care standards into clinical practice in pediatric oncology.

Weiler-Wichtl LJ, Fohn-Erhold V, Schneider C, Schwarzinger A, Krottendorfer K, Pletschko T, Rosenmayr V, Gojo J, Peyrl A, Dieckmann K, Kollmann AS, Hansl R, Slavc I, Fries J, Hopfgartner M, Leiss U. Weiler-Wichtl LJ, et al. Among authors: slavc i. Klin Padiatr. 2023 Nov;235(6):350-359. doi: 10.1055/a-2104-1049. Epub 2023 Jul 21. Klin Padiatr. 2023. PMID: 37494589 Free PMC article.

2

Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.

Slavc I, Schuller E, Czech T, Hainfellner JA, Seidl R, Dieckmann K. Slavc I, et al. J Neurooncol. 1998 Jun-Jul;38(2-3):213-8. doi: 10.1023/a:1005940405165. J Neurooncol. 1998. PMID: 9696374 Clinical Trial.

3

Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma.

Schuller E, Seidl R, Wandl C, Dieckmann K, Slavc I. Schuller E, et al. Among authors: slavc i. Pediatr Hematol Oncol. 2001 Jun;18(4):253-8. doi: 10.1080/088800101750238559. Pediatr Hematol Oncol. 2001. PMID: 11400649

4

Protein profiles of medulloblastoma cell lines DAOY and D283: identification of tumor-related proteins and principles.

Peyrl A, Krapfenbauer K, Slavc I, Yang JW, Strobel T, Lubec G. Peyrl A, et al. Among authors: slavc i. Proteomics. 2003 Sep;3(9):1781-800. doi: 10.1002/pmic.200300460. Proteomics. 2003. PMID: 12973738

5

Proteomic characterization of the human cortical neuronal cell line HCN-2.

Peyrl A, Krapfenbauer K, Slavc I, Strobel T, Lubec G. Peyrl A, et al. Among authors: slavc i. J Chem Neuroanat. 2003 Nov;26(3):171-8. doi: 10.1016/s0891-0618(03)00079-6. J Chem Neuroanat. 2003. PMID: 14615026

6

Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.

Peyrl A, Azizi A, Czech T, Gruber-Olipitz M, Jones N, Haberler C, Prayer D, Autzinger E, Slavc I. Peyrl A, et al. Among authors: slavc i. Pediatr Blood Cancer. 2009 Apr;52(4):476-80. doi: 10.1002/pbc.21881. Pediatr Blood Cancer. 2009. PMID: 19061223 Clinical Trial.

7

Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.

Peyrl A, Sauermann R, Traunmueller F, Azizi AA, Gruber-Olipitz M, Gupper A, Slavc I. Peyrl A, et al. Among authors: slavc i. Clin Pharmacokinet. 2009;48(4):265-71. doi: 10.2165/00003088-200948040-00004. Clin Pharmacokinet. 2009. PMID: 19492871

8

Feasibility and tolerability of bevacizumab in children with primary CNS tumors.

Reismüller B, Azizi AA, Peyrl A, Heinrich M, Gruber-Olipitz M, Luckner D, Rothschild KV, Slavc I. Reismüller B, et al. Among authors: slavc i. Pediatr Blood Cancer. 2010 May;54(5):681-6. doi: 10.1002/pbc.22409. Pediatr Blood Cancer. 2010. PMID: 20066713

9

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.

Peyrl A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K, Schmook MT, Haberler C, Leiss U, Slavc I. Peyrl A, et al. Among authors: slavc i. Pediatr Blood Cancer. 2012 Sep;59(3):511-7. doi: 10.1002/pbc.24006. Epub 2011 Dec 6. Pediatr Blood Cancer. 2012. PMID: 22147459

10

High plasma-GFAP levels in metastatic myxopapillary ependymoma.

Ilhan-Mutlu A, Berghoff AS, Furtner J, Dieckmann K, Slavc I, Czech T, Marosi C, Wagner L, Preusser M. Ilhan-Mutlu A, et al. Among authors: slavc i. J Neurooncol. 2013 Jul;113(3):359-63. doi: 10.1007/s11060-013-1134-2. Epub 2013 Apr 29. J Neurooncol. 2013. PMID: 23624779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters